Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Courtney Nichols"'
Autor:
Nora Colburn, Courtney Nichols, Mark Lustberg, Shandra Day, Michael Haden, Christina Liscynesky
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2, Pp s77-s78 (2022)
Background: An increase in candidemia has been observed throughout the world since the start of the COVID-19 pandemic. Patients with COVID-19 may have different risk factors, clinical presentations, and outcomes compared to patients without COVID-19.
Externí odkaz:
https://doaj.org/article/0775d216f57f45c8bd86f25f3e44aae8
Autor:
Elizabeth Rozycki, Ashley Weiner, Carlos Malvestutto, Nicholas E Kman, Mark Lustberg, Michael Dick, K. Joy Lehman, Ariane Schieber, Lynne Luca, Trisha A Jordan, Erica E Reed, James Allen, Jonathan Parsons, Courtney Nichols, Mark J Conroy
Publikováno v:
Hospital pharmacy. 57(5)
Background: Patients presenting for emergency department (ED) evaluation may be appropriate for treatment with monoclonal antibodies for mild to moderate COVID-19. While many sites have implemented infusion centers for these agents, EDs will continue
Autor:
STUART, ALIX
Publikováno v:
Inc.. Sep2015, Vol. 37 Issue 7, p42-44. 3p. 1 Color Photograph.
Autor:
Courtney Nichols, Mark Lustberg, Mohammad Mahdee Sobhanie, Joy Lehman, Erica E Reed, Nicholas E Kman, Mark Conroy, Michael Dick, James N Allen, Jonathan Parsons, Carlos Malvestutto
Publikováno v:
Open Forum Infectious Diseases
Background Monoclonal antibody therapy (MAT) was granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration for treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults with positive SARS-CoV-2 viral testing
Autor:
Courtney Nichols, Mark Lustberg, Mohammad Mahdee Sobhanie, Joy Lehman, Erica E Reed, Nicholas E Kman, Mark Conroy, Michael Dick, James N Allen, Jonathan Parsons, Carlos Malvestutto
Publikováno v:
Open Forum Infectious Diseases
Background Limited options currently exist for treatment of patients diagnosed with symptomatic coronavirus 2019 (COVID-19). Monoclonal antibody therapy (MAT) has been investigated as a therapeutic option for symptomatic COVID-19 patients in the outp
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e21219 (2011)
Hirschsprung disease (HSCR) is a neurocristopathy characterized by absence of intramural ganglion cells along variable lengths of the gastrointestinal tract. The HSCR phenotype is highly variable with respect to gender, length of aganglionosis, famil
Externí odkaz:
https://doaj.org/article/53ff432ce45f40b58d2c5986ea2aaaac
Autor:
Ryan, Kevin J. (AUTHOR)
Publikováno v:
Inc.. Nov2023, Vol. 45 Issue 5, p98-99. 2p. 2 Color Photographs.
Publikováno v:
Clinical Case Reports
Key Clinical Message This article describes a case involving the resolution of hypsarrhythmia, a generalized abnormal EEG pattern, following focal resection of a cortical tuber in a patient with tuberous sclerosis.
Autor:
Keith Dobney, Deborah Jaques, James Barrett, Cluny Johnstone, John Carrott, Allan Hall, Jerry Herman, Courtney Nichols, Gundula Muldner, Vaughan Grimes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38cb458b6376df9b13827d6a7f6c1650
https://doi.org/10.2307/j.ctt1cfr765.19
https://doi.org/10.2307/j.ctt1cfr765.19
Publikováno v:
Open Forum Infectious Diseases
Background Persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with increased morbidity and mortality. Previous studies have demonstrated lower mortality with combination therapy (CT) compared to monotherapy (MT) fo